Classes Flashcards
H2-receptor antagonists
- block histamine receptors in stomach lining, suppressing gastric acid secretion
- prototype: raNITIdine (Zantac)
- onset: within 1 hr
- duration: 9-12 hr
proton pump inhibitors (PPIs)
- MOA: block exchange of H+ for K+, ↓ acid secretion
- onset: up to 4 days
- duration: 24 hr to 3 days
- greater suppression than H2 blockers
- prototype: omeprazole (Prilosec)
mucosal protectant
- MOA: changes to thick substance in acidic environment, adheres to ulcer to protect from acid, pepsin
- duration: up to 6 hr
- complication: constipation
- prototype: sucralfate (Carafate)
antacids
- MOA: neutralizes stomach acid
- onset: 5 min
- duration: 30-60 min
- aluminum and calcium: constipation
- magnesium: diarrhea
- prototypes
- aluminum hydroxide (Amphojel)
- calcium carbonate (Maalox, Tums, Rolaids)
- magnesium hydroxide (Phillips, Dulcolax)
Prostaglandin E analog
- MOA: mimics prostaglandin, inhibits acid secretion
- Pregnancy Risk Category X (termination)
- prototype: misoprostol (Cytotec)
- onset: 30 min
- duration: 3-6 hr
antiemetics
- glucocorticoid: dexamethasone (Decadron)
- substance P/neurokinin 1 antagonist: aprepitant (Emend)
- serotonin antagonist
- ondansetron (Zofran)
- granisetron (Kytril)
- dopamine antagonist
- promethazine (Phenergan)
- metoclopramide (Reglan)
- cannabinoid: dronabinal (Marinol)
- anticholinergic: scopolamine (Transderm Scop)
- antihistamine
- dimenhydrinate (Dramamine)
- hydroxyzine (Vistaril)
- benzodiazepine: lorazepam (Ativan)
osmotic laxatives
- MOA: draw water into intestines to stimulate BM
- indication: occasional constipation
- complications
- diarrhea
- toxic Mg levels
- dehydration
- caution: kidney impairment
- drugs
- polyethylene glycol 3350 (MiraLax, GlycoLax)
- magnesium hydroxide (Phillips, Dulcolax)
- lactulose
bulk-forming laxatives
- MOA: soften fecal mass, increase bulk (like dietary fiber)
- indications
- temp: constipation
- ↓ diarrhea (diverticulosis and IBS)
- stool control for ileostomy/colostomy
- complications: obstruction; drink plenty of water
- prototype: psyllium (Metamucil)
surfactant laxatives
- MOA: ↓ surface tension of stool, allow penetration of water
- prototype: docusate sodium (Colace)
- indications: constipation, softening of fecal impaction
stimulant laxatives
- MOA: stimulates peristalsis, ↑ volume of water and electrolytes in intestines
- indications: bowel prep (surgery, procedure)
- short-term Tx of constipation (high-dose opioid use)
- used inappropriately for wt loss, get good Hx
- drugs
- bisacodyl (Dulcolax)
- senna (Senokot)
antidiarrheals
- MOA: ↓ GI motility
- complications: constipation
- drugs
- diphenoxylate/atropine (Lomotil)
- loperamide (Imodium)
- paregoric (off market per Davis)
anti-IBS agents
- alosetron (Lotronex)
- MOA: antidiarrheal; blocks 5-HT3 receptors that innervate viscera
- complication: constipation
- lubiprostone (Amitiza)
- MOA: laxative; activates intestinal chloride channels, ↑ fluid secretion
- complication: diarrhea
beta2-adrenergic agonists
- bronchodilator
- inhaled/oral
- end with “terol”
- MOA: activate receptors in smooth muscle to relax, dilate airways; relieve bronchospasm, ↑ ciliary motility
- short-acting
- prototype: albuterol (Ventolin, Pro-Air)
- levalbuterol (Xopenex)
- long-acting
- salmeterol and formoterol
- for significant dz
- combined with short-acting and corticosteroid
- often prescribed together; LABA only for asthma not controlled by SABA alone
- corticosteroid/LABA combos: Advair, Symbicort, Dulera
short-acting beta2-adrenergic agonist
- SABA
- drugs: albuterol (Ventolin, Pro-Air), levalbuterol (Xopenex)
- onset: minutes
- duration: 2-4 hr
- often in combo with LABA for significant dz
long-acting beta2-adrenergic agonist
- LABA
- drugs: salmeterol (Serevent), formoterol
- onset: 10-25 min
- peak and T½: 3-4 hr
- duration: 12
- only used for significant dz
- available in combo with corticosteroid: Advair, Symbicort, Dulera
complications of beta2-adrenergic agonists
- tachycardia, angina
- monitor for
- chest, jaw, arm pain
- palpitations
- check pulse, notify of ↑ > 20-30 bpm
- avoid caffeine
- possible ↓ dose
- monitor for
- tremors: usually resolved with continued use
contraindications and precautions for beta2-adrenergic agonists
- pregnancy risk: C
- contra: tachydysrhythmia
- caution
- DM (↑ BG): effects usually transient and slight except with ↑ doses
- HTN
- hyperthyroid
- heart dz
- angina
interactions with beta2-adrenergic agonists
- ↑ risk of angina and tachycardia: MAOIs and TCAs
- beta blockers (metoprolol, propranolol): negates effects of both
administering beta2-adrenergic agonists
- pt education: use before using inhaled corticosteroid
- use SABA for acute episode
- LABAs
- Q12H
- NOT for acute attack
- always used with inhaled corticosteroid
- have pt return demonstrate
- follow manufacturer instructions
evaluation of effectiveness of SABAs and LABAs
- control of asthma
- improved Sx: clearing/improved breath sounds, ↓ wheezing and coughing, ↓ breathing effort
- pt able to exercise without dyspnea
anticholinergics
- prototype: ipratropium (Atrovent)
- end with “pium”
- oral/inhaled
- MOA: blocks muscarinic receptors of bronchi; bronchodilation
- uses: relieves COPD-related and allergen- and exercise-induced bronchospasm
- off-label: asthma Tx
complications of anticholinergics
- dry mouth, hoarseness: sip fluids, suck on sugar-free hard candy
- blurred vision
- ↑ IOP
- hot, flushed skin
- dry skin
- bradycardia → tachycardia, palpitations, aarhythmias
- urinary retention
- constipation
- rare: fever, confusion, mania, hallucinations, rashes
contraindicaitons and precautions for anticholinergics
- pregnancy: B
- contra: allergy to peanuts
- caution
- narrow-angle glaucoma
- benign prostatic hyperplasia
administering anticholinergics
- rinse mouth after use (bad taste
- wait 5 min between inhaled meds
methylxanthines
- prototype: theophylline
- end with “phylline”
- MOA: relax bronchial smooth muscle, bronchodilation
- oral, IV (emergency only)
- acts like caffeine
- for long-term control of chronic asthma, COPD

complications of methylxanthines
- mild toxicity: GI distress, restlessness
- severe adverse at higher dose
- dysrhythmias: lidocaine
- sz: diazepam
- serum monitoring required, narrow therapeutic range
glucocotricoids for respiratory disorders
- steroidal anti-inflammatory
- oral, inhaled, IV
- end with “one”
- prototypes
- beclomethasone (Qvar), inhaled
- prednisone
- inhaled, combo with LABAs
- budesonide
- fluticasone
- mometasone
- IV
- hydrocortisone
- methylprednisolone
uses for glucocorticoids in the Tx of respiratory disorders
- prevent inflammation
- suppress airway mucus production
- reduce airway edema
- inhaled: used as prophylaxis
- IV: short-term for status asthmaticus
- PO
- short-term: acute exacerbation
- long-term: severe asthma
complications of glucocorticoids
- inhaled
- difficulty speaking
- hoarseness
- oral candidiasis: rinse mouth after use, monitor for s/sx of infection and report
- ↓ production of glucocorticoids in adrenal gland: taper, do not stop abruptly
- bone loss
- hyperglycemia, glucosuria
- PUD: give with food, avoid NSAIDs, watch for GI bleed
- ↑ risk of infection
- wt/fluid gain
- increased hunger
contraindications and precautions of glucocorticoids
- pregnancy: C
- contra
- recent live virus vaccine
- systemic fungal infection
- caution
- children
- DM
- HTN
- heart failure
- PUD
- osteoporosis
- kidney dysfunction
interactions with glucocorticoids
- ↑ risk for hypokalemia with K+-depleting diuretics
- ↑ risk for ulceration with NSAIDs
- in DM: counteracts effects of meds, ↑ blood sugar
- may need higher dose of antidiabetics
administering glucorticoids
- pt education
- use on fixed schedule
- NOT for acute asthma episode
- use beta2-adrenergic first: bronchodilation → better absorption of glucocorticoid
- oral: for short-term use, 3-10 days after acute attack
- long-term therapy, switch to inhaled: ↑ dose during stress
leukotriene modifiers
- prototype: montelukast (Singulair)
- other: zileuton, zafirlukast
- MOA: ↓ inflammation, bronchoconstriction, edema, mucus
- long-term therapy of asthma in adults, children
- prevention of exercise-induced bronchospasm
complications of leukotriene modifiers
- depression, suicidal ideation: watch for changes, report
- liver injury (zileuton and zafirlukast): get baseline LFTs and monitor
precautions for leukotriene modifiers
- pregnancy: B
- liver dysfunction
interactions with leukotriene modifiers
- zileuton and zafirlukast
- ↑ levels of warfarin: monitor for s/sx of bleeding, PT, INR
- ↑ levels of theophylline: monitor level, educate about s/sx of toxicity (N&V, sz)
- montelukast: ↓ effects with phenytoin
administering leukotriene modifiers
- take as prescribed
- montelukast
- maintenance: daily HS
- prevention, exercise-induced: 2 hr before
opioid antitussives
- prototype: codeine
- other: hydrocodone
- MOA: acts on CNS to increase cough reflex threshold
- uses: ↓ frequency, intensity of chronic dry cough
complications of opioid antitussives
- dizziness
- lightheadedness
- drowsiness
- respiratory depression
- N&V: take with food
- constipation: ↑ fiber and fluid intake
nursing actions for opioid antitussives
- monitor VS for bradypnea (RR < 12)
- monitor ambulation, assist in and out of bed (fall risk)
- short-term use only, risk of abuse
contraindications and precautions for opioid antitussives
- pregnancy: C
- contra
- respiratory depression
- head trauma
- acute asthma
- liver and renal dysfunction
- acute ETOH disorder
- caution
- children
- older adults
- hx of substance abuse
pt education for opioid antitussives
- avoid activities requiring alertness
- lie down if dizzy
- get up slowly
- avoid ETOH, other CNS depressants
nonopioid antitussives
- prototype: dextromethorphan (Delsym, Robitussin)
- MOA: acts on CNS to suppress cough
- uses: cough suppression, ↑ pain reduction with opioid
- pregnancy: C
complications of nonopioid antitussives
- mild nause, dizziness, sedation
- at high dose: euphoria, risk for abuse
interactions with nonopioid antitussives
MAOI: life-threatening serotonin syndrome if taken within 2 wks
administering nonopioid antitussives
- some products contain ETOH and/or sucrose
- available in capsules, lozenges, liquids, syrups
expectorants
- prototype: guaifenesin (Mucinex, Robitussin)
- MOA: promotes productive cough, thins secretions
- uses: clear airway of mucus
- available in combo with antitussives or decongestants
complications of expectorants
- GI distress: take with food
- drowsiness, dizziness: avoid driving, etc.
contraindications and precautions for expectorants
- pregnancy: C
- talk with provider if breastfeeding
- may be contraindicated in children
administering expectorants
- ↑ fluids to thin secretions
- available in tablets, capsules, syrups
- pt education: READ LABELS (often in combos) to avoid unintentional OD
mucolytics
- prototype: acetylcysteine (Mycomyst)
- other: hypertonic saline
- MOA: thin and enhance flow of secretions
- use: acute, chronic pulmonary disorders; cystic fibrosis, antidote for acetaminophen poisoning
complications of mucolytics
- PO: aspiration and bronchospasm
- dizziness, drowsiness, hypotension, tachycardia: monitor VS, fall risk
- hepatotoxicity: monitor LFTs
precautions for mucolytics
- pregnancy: B
- asthma
- hypothyroidism
- CNS depression
- renal and liver dz
- sz disorder
administering mucolytics
- smells like rotten eggs
- inhaled, PO, IV
- in acetaminophen OD, monitor
- LFTs
- PT
- BUN
- glucose
- electrolytes
- acetaminophen level
decongestants
- prototype: phenylephrine
- other: ephedrine, naphazoline (ophthalmic), pseudoephedrine
- MOA: stim of alpha1-adrenergic receptors, ↓ inflammation of nasal membrane
- uses: allergic or non-allergic rhinitis, sinusitis, common cold
- sympathomimetic
complications of decongestants
- rebound congestion (topical use): use 3-5 days max, taper
- agitation, nervousness: report and stop med
- vasoconstriction: avoid with HTN, cerebrovascular dz, CAD, dysrhythmias
contraindications and precautions for decongestants
- contra: closed-angle glaucoma
- caution
- HTN
- cerebrovascular dz
- CAD
- dysrhythmias
administering decongestants
- topical
- associated with rebound congestion
- work faster
- more effective
- shorter duration
- systemic effects uncommon
- oral
- effects similar to amphetamine
- ID needed to purchase OTC
antihistamines
- 1st generation
- diphenhydramine (Benadryl)
- promethazine (Phenergan)
- dimenhydrinate (Dramamine)
- 2nd generation
- loratadine (Claritin)
- cetirizine (Zyrtec)
- fexofenadine (Allegra)
- desloratadine (Clarinex)
- intranasal
- azelastine
- olopatadine
antihistamines MOA, uses
- MOA: act on H1 receptors and block histamine release caused by allergic reaction
- uses
- mild allergic reaction
- anaphylaxis
- motion sickness
- insomnia
- nausea
- with sympathomimetic for nasal decongestion
antihistamine complications
- sedation: take at night, avoid ETOH/CNS depressants, caution during driving, etc.
- dry mouth
- GI distress: take with food, ↑ fluids and fiber
- acute toxicity, excitation, hallucinations, incoordination, sz, high fever: activated charcoal, cathartic
- premoethazine: resp. depression and tissue injury at IV site
contraindications and precautions for antihistamines
- contra
- 3rd trimester, breastfeeding, newborns
- promethazine: children < 2 yr, liver dz, MAOI use, dysrhythmias
- caution
- children
- older adults
- sz disorder
- heart dz
- renal dz
- urinary retention
- open-angle glaucoma
- HTN
- prostate hypertrophy
- asthma
interactions with
- ETOH
- other CNS depressants
administering antihistamines
more sedative effect with 1st generation
nasal glucocorticoids
- prototype: mometasone (Nasonex)
- other: fluticasone (Flonase), triamcinolone (Nasocort), budesonide (Rhinocort)
- MOA: ↓ inflammation in allergic rhinitis; first-line Tx
- uses: allergic rhinitis (sneezing, itching, drainage, congestion)
complications and precautions for nasal glucocorticoids
- SE
- sore throat
- nosebleed
- headache
- burning
- pregnancy: C
administering nasal glucocorticoids
- dosing is daily
- seasonal allergies: 7+ days for max benefit
- perennial allergies: 21+ days for full effect
- may need topical decongestant before using
Tx for asthma includes what classes of drugs? (BAM/SLM)
- Beta2-adrenergic agonists (bronchodilators)
- Anticholinergic
- Methylxanthines
- anti-inflammatories
- Steroids (glucocorticoids)
- Leukotriene modifiers
- Mast cell stabilizers
non-opioid analgesics
- acetaminophen, NSAIDs
- for mild to moderate pain
- also antipyretics
non-steroidal anti-inflammatory drugs (NSAIDs)
- MOA: inhibit inflammatory effects of COX-1 and/or COX-2
- ↓ pain, inflammation, fever
- 1st-generation (COX-1 and COX-2)
- aspirin
- ibuprofen (Advil, Motrin)
- naproxen (Aleve)
- indomethacin
- diclofenac
- ketorolac
- meloxicam
- 2nd-generation (COX-2 only)
- celecoxib (Celebrex)
complications of NSAIDs
- ↑ risk of GI ulcer, bleeding, renal impairment
- take with food or adjuvant GI protectant
- monitor for s/sx of GI bleed, other bleeding
- celecoxib: ↑ risk of MI/stroke
- aspirin: ↓ risk of MI/stroke
precautions for NSAIDs
- older age
- smoking
- alcohol use disorder
- renal impairment
- GI issues
- pregnancy
- bleeding disorders
- use of anticoagulant meds
administering NSAIDs
- mostly PO; some IV and IM forms
- stop OTC aspirin 1 wk before procedures/surgery
- don’t crush or chew enter-coated pills
- notify provider of bleeding, N&V, abd pain
interactions with NSAIDs
- ↑ risk of bleeding with warfarin, glucocorticoids
- ↑ all risks: concurrent use of multiple NSAIDs
Reye syndrome
- rare but serious
- when ASA used in children with viral illness
- DO NOT treat pediatric fever with ASA
- s/sx
- diarrhea
- tachypnea
- vomiting
- severe fatigue
- fever
- hypoglycemia → confusion, sz, LOC
salicylism
- mild ASA toxicity
- max dose: 4 g/day
- s/sx
- tinnitus
- sweating
- HA
- dizziness
- respiratory alkalosis
- stop taking and contact provider
- → toxicity
aspiring toxicity
- max dose: 4 g/day
- s/sx
- high fever
- sweating
- acidosis
- dehydration
- electrolyte imbalance
- coma
- respiratory depression
- medical emergency
- Tx
- gastric lavage/activated charcoal
- hemodialysis
- cooling with tepid water
- IV fluid correction
- bicarb for acidosis
acetaminophen
MOA: slows production of prostaglandins in CNS
acetaminophen considerations
- max dose: 4 g/day
- ETOH
- use caution if > 1-2 drinks/day
- max dose: 2 g/day
- use cautiously with warfarin: monitor PT, INR
- liver dysfunction: check LFTs before giving
- pt education: READ LABELS, don’t accidentally OD by taking multiple acetaminophen combos
- monitor for concurrent admin with combos
acute acetaminophen toxicity
- rare at therapeutic dose
- → liver damage
- s/sx
- N&V
- diarrhea
- sweating
- abd pain
- liver failure
- coma
- death
- max dose: 4 g/day
- antidote: acetylcysteine
opioid agonists
- prototype: morphine
- fentanyl
- meperidine
- methadone
- codeine
- oxycodone
- hydromorphone
side effects of opioid agonists
- worse with ETOH, CNS depressants
- respiratory depression: monitor VS
- sedation: fall risk, avoid driving, etc.
- constipation
- prevention/mild: ↑ fluid and fiber, docusate sodium
- acute: stimulant laxative
- long-term opioid use: opioid antagonist
- N&V: give antiemetic (promethazine is synergist), worse with antihypertensives
- urinary retention
- monitor I&O
- encourage voiding Q4H
- assess for distention
- worse with BPH, concurrent anticholinergics
opioid agonist long-term use
- physical dependence
- can → abuse, illicit use
- withdrawal: taper use
- tolerance
- diminished therapeutic response
- no relief or SE from normal dose
opioid agonist acute overdose
- s/sx
- respiratory depression
- coma
- pinpoint pupils
- Tx
- stop med
- CPR
- naloxone
- mechanical ventilation
administering opioid agonists
- always assess pain level first and medicate per level
- reassess an appropriate amount of after admin according to route
- monitor respiratory status
- do not over-medicate
- fixed schedule for severe chronic pain
- PRN for acute pain, giving meds before pain is severe
agonist-antagonist opioids
- MOA: agonist for Kappa opioid receptors, antagonist for Mu
- for moderate to severe pain
- ideal for labor pain
- compared to opioid agonists
- ↓ effective
- ↓ respiratory depression
- ↓ risk of abuse
- drugs
- prototype: butorphanol
- nalbuphine
- buprenorphine
- penazocine
complications of opioid agonist-antagonists
- sedation
- respiratory depression
- dizziness: fall risk, avoid machinery, etc.
- headache
- abstinence syndrome
- ↓ activity of Mus → withdrawal in opioid-dependent pt
- cramping
- HTN
- vomiting
- fever
- anxiety
contraindications and precautions for opioid agonist-antagonists
- contra: opioid use disorder
- caution
- chronic dz
- head injury
opioid antagonists
- MOA: compete for receptors, blocking opioid action
- drugs
- prototype: naloxone
- methylnaltrexone
- alvimopan
- use: reverses respiratory depression, euphoria, constipation, and pain control
complications of opioid antagonists
- tachycardia
- tachypnea
contraindications for opioid antagonists
opioid dependency, except in case of OD
tricyclic antidepressants
- uses: depression, adjuvant for fibromyalgia, nerve pain (usually chronic)
- prototype: amitriptyline
- SE
- orthostatic hypotension: avoid falls
- sedation: avoid driving, etc.
- anticholinergic effect: ↑ fluid, comfort measures
- contraindications/precautions
- recent MI
- taking MAOI
- glaucoma
- BPH
- Sz
- liver dz
- kidney dz
anticonvulsants
- uses: sz prevention, adjuvant for neuropathy pain (common in DM)
- drugs: carbamazepine, gabapentin
- lots of interactions
contraindications and precautions for anticonvulsants
- bone marrow suppression
- MAOI use
- pregnancy
interactions with anticonvulsants
- warfarin
- oral contraceptives
- grapefruit
- other anticonvulsants
- CNS depressants
complications of anticonvulsants
- drowsiness: take at night, avoid driving
- GI upset: take with food, ↑ fluid and fiber, stool softener, laxative
- bone marrow suppression: monitor for bruising, bleeding, sore throat, and fever
- rash: HOLD and notify provider
CNS stimulants
- prototype: methylphenidate
- MOA: ↑ analgesia, ↓ sedation
- monitor for wt loss
- SE: insomnia (take before 1600, ↓ caffeine
- caution
- HTN
- Hx of substance use disorder
- OTC meds
- contra
- MAOI use
muscle relaxants/antispasmodics
- centrally acting
- diazepam (Valium)
- baclofen
- cyclobenzaprine (Flexeril)
- tiZANidine (Zanaflex)
- peripherally acting
- dantrolene (Dantrium)
- interactions: CNS depressants, additive effects
- precautions: liver and kidney impairment, pregnancy
migraine medications
- acute: not more than 2x/wk
- NSAIDs
- acetaminophen
- triptans
- ergots
- prophylactic
- TCAs
- anticonvulsants
- beta blockers
- estrogens
triptans
- for Tx of acute migraine
- all names end in “triptan”
- contraindications
- ischemic heart dz
- liver failure
- uncontrolled HTN
- interactions
- do not take with: ergots, MAOIs or below drugs
- ↑ risk of serotonin syndrome
- St. John’s wort
- SSRIs, SNRIs, TCAs
- other triptans
- bupropion (Wellbutrin)
- buspirone (BuSpar)
- meperidine (Demerol)
ergots
- for Tx of acute migraine
- all have “ergot” in the name
- contraindications: renal, liver dysfunction; CAD; HTN
- pregnancy category X: use contraception
beta blockers
- Tx of HTN, tachyarrhythmias, angina, MI, HF, hyperthyroidism
- prevention of migraine
- all end in “lol”
- monitor for orthostatic hypotension
- caution: pregnancy, lactation, lung dz, DM, severe liver dz
- do not stop abruptly in pts with CV dz
- interactions
- bronchodilators: ↓ effect
- other meds that slow the heart: + effect
- DM meds: alter dose
- cimetidine: ↓ metabolism, ↑ effects of beta blocker
neuromuscular blockers
- MOA: block ACh at neuromuscular junction → muscle relaxation, hypotension; paralysis without LOC or analgesia
- use: facilitate intubation, control muscles during ECT
- drugs
- succinylcholine: can cause MH; treat with dantrolene
- pancuronium: reversed by neostigmine
- must have airway and mechanical vent stat
- monitor for return of respiratory ftn
IV sedatives and anesthetics
- giving in anesthetic context requires additional training
- non-opioid sedation
- barbiturates: phenobarbital
- benzodiazepines (preop, conscious sedation)
- midazolam (Versed): induces amnesia
- diazepam (Valium)
- lorazepam (Ativan)
- propofol
- ketamine
- opioid analgesia
- fentanyl
- morphine
anesthesia care
- pt continuously monitored 1-on-1 by RN
- RN must be trained in ACLS and admin of sedation
- administer slowly
- after admin, monitor for
- VS return to baseline
- orientation x4
- pt can void within 8 hr
- control of N&V
- no driving for pt
anticoagulants
- MOA: activate anti-thrombin, inactivate thrombin and factor Xa
- parenteral
- drugs
- unfractionated: heparin
- low molecular weight
- enoxaparin
- dalteparin
- activated factor Xa inhibitor: fondaparinux
vitamin K inhibitors
- prototype: warfarin
direct thrombin inhibitors
direct factor Xa inhibitors
antiplatelets
thrombolytic meds
contraindications and precautions for anticoagulants
- contra
- thrombocytopenia
- uncontrolled bleeding
- surgery of eyes, brain, spinal cord
- lumbar puncture
- regional anesthesia
- caution
- hemophilia
- PUD
- severe HTN
- liver or kidney dz
- threatened abortion